Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (79 ops.)
Latest filing published 08 Jul 2021 for Beam Therapeutics Inc., €38k.
Insider track record
Disclosed buys
0
Disclosed sells
79
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Graham K. Cooper: trading record in brief
Graham K. Cooper, listed as senior executive, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Orexigen Therapeutics, Inc., Beam Therapeutics Inc. and Receptos, Inc. We count 91 filings; the first trade dates from 20 November 2007 and the latest from 6 July 2021.
On the market, this insider has only sold: 79 sales, €4.4M in total. Besides market trades, the filings include 3 share grants and 8 option exercises. In 2021 alone, the filings show no purchases and 17 sales.
Most recently, on 8 July 2021, the filings show an open-market sale worth €32k in Beam Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Graham K. Cooper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,614 shares@ US$17.0018.0% of flowCommon StockSEC:0000899243-21-027902:0
12,045 shares@ US$17.0082.0% of flowCommon StockSEC:0000899243-21-026782:0
2 of 2 declarations
